drugset / Trial / NCT02904304
Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
RandomizedParallel-groupQuadruple-blindTreatment
Summary
National clinical trial, phase III, multicenter, randomized, prospective, double-blind, parallel, placebo-controlled, which one hundred and fifty (150) subjects of both sexes aged equal or more than 18 years will be randomly allocated to one the drug group or placebo group.
Timeline
- Start
- 2020-12
- Primary completion
- 2021-07
- Completion
- 2021-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desloratadine | Small molecule | 2.5 mg | Oral |
| Subject | Ibuprofen | Small molecule | 400 mg | Oral |
| Subject | Phenylephrine | Small molecule | 20 mg | Oral |
Indications
No indication recorded.